Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03035266 · ClinicalTrials.gov registry record · NA
The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery
A NA study, sponsored by Keller Army Community Hospital.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03035266: Completed NA study, sponsored by Keller Army Community Hospital.
NCT03035266 is a NA study that has completed, run by Keller Army Community Hospital. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03035266, a NA study, has completed, sponsored by Keller Army Community Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The investigators will compare differences in quadriceps strength, leg girth, and functional outcome scores between two groups of patients after weeks 6 and 12 as well as 6 months following meniscus or articular cartilage repair/restoration requiring 6 weeks of non-weight bearing or limited weight bearing status in a brace at 0° degrees of knee extension. One group will receive BFR with standard post-operative rehabilitation for 12 weeks followed by the standard protocol progression for the remainder of the treatment program. The other group will receive standard post-operative rehabilitation without BFR for the duration of treatment program.
Primary Outcome
Change in isokinetic peak torque knee extension and knee flexion at 180 degrees/sec and at 300 degrees/second
Interventions
- OTHER Blood Flow Restriction
- OTHER Standard rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-04-05 |
| Est. Completion | 2020-03-12 |
| Phase | NA |
What the finished NCT03035266 record still lists
NCT03035266 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Blood Flow Restriction is the first listed.
NCT03035266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03035266 about?
NCT03035266 is a clinical study titled "The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery". The investigators will compare differences in quadriceps strength, leg girth, and functional outcome scores between two groups of patients after weeks 6 and 12 as well as 6 months following meniscus or articular cartilage repair/restoration requiring 6 weeks of non-weight bearing or limited weight b...
What is the current status of trial NCT03035266?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-04-05. Estimated completion is 2020-03-12.
What interventions are being tested in trial NCT03035266?
The interventions under investigation include: Blood Flow Restriction (OTHER), Standard rehabilitation (OTHER).
Who is sponsoring clinical trial NCT03035266?
This trial is sponsored by Keller Army Community Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03035266's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI